RVMD
Revolution Medicines, Inc.
Key figures
| Metric | Latest |
|---|---|
| Revenue | $02025 |
| Gross profit | $197MQ3 2026 |
| Operating income | −$1.7B |
| Net income | −$1.9B |
| EPS | −$9.13 |
| Free cash flow | −$1.4B |
Revolution Medicines, Inc.
| Metric | Latest |
|---|---|
| Revenue | $02025 |
| Gross profit | $197MQ3 2026 |
| Operating income | −$1.7B |
| Net income | −$1.9B |
| EPS | −$9.13 |
| Free cash flow | −$1.4B |